{"id":"https://openalex.org/W4409429450","doi":"https://doi.org/10.1016/j.omtm.2025.101466","title":"Species-specific gene expression manipulation in humanized livers of chimeric mice via siRNA-encapsulated lipid nanoparticle treatment","display_name":"Species-specific gene expression manipulation in humanized livers of chimeric mice via siRNA-encapsulated lipid nanoparticle treatment","alternate_titles":[],"publication_year":2025,"publication_date":"2025-04-14","ids":{"openalex":"https://openalex.org/W4409429450","doi":"https://doi.org/10.1016/j.omtm.2025.101466","pmid":"https://pubmed.ncbi.nlm.nih.gov/40927764","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12415978"},"language":"en","primary_location":{"id":"doi:10.1016/j.omtm.2025.101466","doi":"https://doi.org/10.1016/j.omtm.2025.101466","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtm.2025.101466","pdf_url":null,"source":{"id":"https://openalex.org/S2764588101","display_name":"Molecular Therapy \u2014 Methods & Clinical Development","issn_l":"2329-0501","issn":["2329-0501"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy Methods &amp; Clinical Development","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4409429450"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.omtm.2025.101466","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010073458","display_name":"Kazuto Yamazaki","orcid":"https://orcid.org/0000-0002-4130-3740","observed_orcids":["https://orcid.org/0000-0002-4130-3740"]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kazuto Yamazaki","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan"],"raw_orcid":"https://orcid.org/0000-0002-4130-3740","affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065486664","display_name":"Kenji Kubara","orcid":"https://orcid.org/0009-0008-1125-2226","observed_orcids":["https://orcid.org/0009-0008-1125-2226"]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Kubara","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006662377","display_name":"Go Sugahara","orcid":"https://orcid.org/0000-0002-1884-9833","observed_orcids":["https://orcid.org/0000-0002-1884-9833"]},"institutions":[{"id":"https://openalex.org/I4210124309","display_name":"PhoenixBio (Japan)","ror":"https://ror.org/03423rs03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210124309"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Go Sugahara","raw_affiliation_strings":["Research and Development Department, PhoenixBio Co., Ltd., 3-4-1, Kagamiyama, Higashi-Hiroshima, Hiroshima 739-0046, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Department, PhoenixBio Co., Ltd., 3-4-1, Kagamiyama, Higashi-Hiroshima, Hiroshima 739-0046, Japan","institution_ids":["https://openalex.org/I4210124309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059902219","display_name":"Hiroki Muto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroki Muto","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100921674","display_name":"Masae Yamamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masae Yamamoto","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045436087","display_name":"Yuji Mano","orcid":"https://orcid.org/0000-0002-8537-951X","observed_orcids":["https://orcid.org/0000-0002-8537-951X"]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuji Mano","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075321389","display_name":"Kaoru Ogawa Mitsuhashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kaoru Mitsuhashi","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan","institution_ids":["https://openalex.org/I55881946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052923598","display_name":"Chihiro Yamasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124309","display_name":"PhoenixBio (Japan)","ror":"https://ror.org/03423rs03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210124309"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chihiro Yamasaki","raw_affiliation_strings":["Research and Development Department, PhoenixBio Co., Ltd., 3-4-1, Kagamiyama, Higashi-Hiroshima, Hiroshima 739-0046, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Department, PhoenixBio Co., Ltd., 3-4-1, Kagamiyama, Higashi-Hiroshima, Hiroshima 739-0046, Japan","institution_ids":["https://openalex.org/I4210124309"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yuji Ishida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]},{"id":"https://openalex.org/I4210124309","display_name":"PhoenixBio (Japan)","ror":"https://ror.org/03423rs03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210124309"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuji Ishida","raw_affiliation_strings":["Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8553, Japan","Research and Development Department, PhoenixBio Co., Ltd., 3-4-1, Kagamiyama, Higashi-Hiroshima, Hiroshima 739-0046, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8553, Japan","institution_ids":["https://openalex.org/I113306721"]},{"raw_affiliation_string":"Research and Development Department, PhoenixBio Co., Ltd., 3-4-1, Kagamiyama, Higashi-Hiroshima, Hiroshima 739-0046, Japan","institution_ids":["https://openalex.org/I4210124309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008377317","display_name":"Chise Tateno","orcid":"https://orcid.org/0000-0002-2640-3268","observed_orcids":["https://orcid.org/0000-0002-2640-3268"]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]},{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]},{"id":"https://openalex.org/I4210124309","display_name":"PhoenixBio (Japan)","ror":"https://ror.org/03423rs03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210124309"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Chise Tateno","raw_affiliation_strings":["Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8553, Japan","Research and Development Department, PhoenixBio Co., Ltd., 3-4-1, Kagamiyama, Higashi-Hiroshima, Hiroshima 739-0046, Japan","School of Pharmaceutical Sciences, Wakayama Medical University, 25-1, Shichibancho, Wakayama 640-8156, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8553, Japan","institution_ids":["https://openalex.org/I113306721"]},{"raw_affiliation_string":"Research and Development Department, PhoenixBio Co., Ltd., 3-4-1, Kagamiyama, Higashi-Hiroshima, Hiroshima 739-0046, Japan","institution_ids":["https://openalex.org/I4210124309"]},{"raw_affiliation_string":"School of Pharmaceutical Sciences, Wakayama Medical University, 25-1, Shichibancho, Wakayama 640-8156, Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009765874","display_name":"Yuta Suzuki","orcid":"https://orcid.org/0000-0001-6240-8552","observed_orcids":["https://orcid.org/0000-0001-6240-8552"]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuta Suzuki","raw_affiliation_strings":["Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., Ltd., Tsukuba Research Laboratories, 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan","institution_ids":["https://openalex.org/I55881946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5008377317","https://openalex.org/A5010073458"],"corresponding_institution_ids":["https://openalex.org/I113306721","https://openalex.org/I190805021","https://openalex.org/I4210124309","https://openalex.org/I55881946"],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":{"value":3900,"currency":"USD","value_usd":3900},"fwci":1.0784,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.71111445,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"33","issue":"2","first_page":"101466","last_page":"101466"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/humanized-liver","display_name":"humanized liver","score":0.6119999885559082},{"id":"https://openalex.org/keywords/cytochrome-p450-oxidoreductase","display_name":"cytochrome P450 oxidoreductase","score":0.8690000176429749},{"id":"https://openalex.org/keywords/warfarin-pharmacokinetics","display_name":"warfarin pharmacokinetics","score":0.8270000219345093},{"id":"https://openalex.org/keywords/prealbumin","display_name":"prealbumin","score":0.7070000171661377},{"id":"https://openalex.org/keywords/sirna-specificity","display_name":"siRNA specificity","score":0.31299999356269836}],"concepts":[{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.5603877305984497},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.5158676505088806},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.4876345694065094},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4730721414089203},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.47233834862709045},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.44762253761291504},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.4393216669559479},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.43286556005477905},{"id":"https://openalex.org/C22615655","wikidata":"https://www.wikidata.org/wiki/Q203221","display_name":"Small interfering RNA","level":4,"score":0.4229656755924225},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38446271419525146},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.37767156958580017},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34075507521629333},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.24632295966148376},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21623775362968445},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1630784273147583},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.12792736291885376}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.omtm.2025.101466","doi":"https://doi.org/10.1016/j.omtm.2025.101466","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtm.2025.101466","pdf_url":null,"source":{"id":"https://openalex.org/S2764588101","display_name":"Molecular Therapy \u2014 Methods & Clinical Development","issn_l":"2329-0501","issn":["2329-0501"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy Methods &amp; Clinical Development","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12415978","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12415978/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12415978/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther Methods Clin Dev","raw_type":"Text"},{"id":"pmid:40927764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40927764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy. Methods & clinical development","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:65306dca2504448884ceea0aff34a233","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/65306dca2504448884ceea0aff34a233","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Therapy: Methods & Clinical Development, Vol 33, Iss 2, Pp 101466- (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.omtm.2025.101466","doi":"https://doi.org/10.1016/j.omtm.2025.101466","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtm.2025.101466","pdf_url":null,"source":{"id":"https://openalex.org/S2764588101","display_name":"Molecular Therapy \u2014 Methods & Clinical Development","issn_l":"2329-0501","issn":["2329-0501"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","ki-jl-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy Methods &amp; Clinical Development","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4409429450.pdf","grobid_xml":"https://content.openalex.org/works/W4409429450.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1531091076","https://openalex.org/W1983773316","https://openalex.org/W2019819564","https://openalex.org/W2030944573","https://openalex.org/W2047821701","https://openalex.org/W2051374865","https://openalex.org/W2052378662","https://openalex.org/W2055894442","https://openalex.org/W2062641600","https://openalex.org/W2064253765","https://openalex.org/W2089150369","https://openalex.org/W2090952221","https://openalex.org/W2094664566","https://openalex.org/W2096565553","https://openalex.org/W2102230836","https://openalex.org/W2106885643","https://openalex.org/W2151239266","https://openalex.org/W2166143354","https://openalex.org/W2417280822","https://openalex.org/W2568407693","https://openalex.org/W2899619911","https://openalex.org/W2918194956","https://openalex.org/W2992823069","https://openalex.org/W3015140168","https://openalex.org/W3040633579","https://openalex.org/W3048788919","https://openalex.org/W3063613132","https://openalex.org/W3086708477","https://openalex.org/W3164272509","https://openalex.org/W3199618457","https://openalex.org/W3207886513","https://openalex.org/W4210268003","https://openalex.org/W4281728438","https://openalex.org/W4283398179","https://openalex.org/W4294167180","https://openalex.org/W4313480728","https://openalex.org/W4315884131","https://openalex.org/W4317103544","https://openalex.org/W4317678901","https://openalex.org/W4382929851","https://openalex.org/W4386813746","https://openalex.org/W4393316181"],"related_works":["https://openalex.org/W4294167180","https://openalex.org/W2652420020","https://openalex.org/W4417335719","https://openalex.org/W2051374865","https://openalex.org/W4286728249","https://openalex.org/W2162377452","https://openalex.org/W2071832730","https://openalex.org/W2088308231","https://openalex.org/W1976889212","https://openalex.org/W2128453363"],"abstract_inverted_index":{"Liver-humanized":[0],"chimeric":[1,25],"mice":[2,26],"(PXB-mice)":[3],"are":[4],"widely":[5],"utilized":[6],"for":[7,66],"predicting":[8],"human":[9,14,31,125],"pharmacokinetics":[10],"(PK)":[11],"and":[12,51,79,112,123,141,196,200],"as":[13],"disease":[15],"models.":[16,54],"However,":[17],"residual":[18],"metabolic":[19],"activity":[20,139],"of":[21,49,96,146,152,194],"mouse":[22,67,115,130,192],"hepatocytes":[23,193],"in":[24,63,77,88,109,136,149,170,176,189],"can":[27],"interfere":[28],"with":[29,134,156],"accurate":[30],"PK":[32,168],"estimation.":[33],"Lipid":[34],"nanoparticle":[35],"(LNP)-formulated":[36],"small":[37],"interfering":[38],"RNA":[39],"(siRNA)":[40],"treatment":[41,161],"makes":[42],"it":[43],"possible":[44],"to":[45,58,81,174,185],"eliminate":[46],"the":[47,85,110,143,150,165,190],"shortcomings":[48],"chimeras":[50],"create":[52,59,197],"new":[53,61],"Therefore,":[55],"we":[56],"aimed":[57],"a":[60,92,182],"model":[62],"which":[64],"siRNA":[65,99,133],"cytochrome":[68],"P450":[69],"oxidoreductase":[70],"(":[71,102],"Por":[72,131,147],")":[73,104],"gene":[74,187],"was":[75],"encapsulated":[76],"LNP":[78],"administered":[80,154],"PXB-mice.":[82,205],"We":[83,128],"validated":[84],"siRNA-LNP":[86,180],"system":[87,184],"PXB-mice,":[89],"showing":[90],"that":[91,175],"single":[93],"intravenous":[94],"injection":[95],"LNP-formulated":[97],"mouse-specific":[98,179],"against":[100],"transthyretin":[101],"Ttr":[103,107],"knocked":[105],"down":[106],"expression":[108,122,148,188],"liver":[111],"decreased":[113],"plasma":[114,124],"TTR":[116,121,126],"levels":[117],"without":[118],"affecting":[119],"hepatic":[120],"levels.":[127],"produced":[129],"-specific":[132],"high":[135],"vitro":[137],"silencing":[138],"(siPOR(Mm))":[140],"confirmed":[142],"efficient":[144],"knockdown":[145],"livers":[151],"PXB-mice":[153,171,195],"intravenously":[155],"LNP-encapsulated":[157],"siPOR":[158],"(siPOR(Mm)/LNP).":[159],"siPOR(Mm)/LNP":[160],"suppressed":[162],"4\u2032-hydroxywarfarin,":[163],"making":[164],"S":[166],"-warfarin":[167],"profile":[169],"more":[172,198],"similar":[173],"humans.":[177],"Thus,":[178],"is":[181],"simple":[183],"control":[186],"remaining":[191],"humanized":[199],"invaluable":[201],"models":[202],"based":[203],"on":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4409429450","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-04-15T00:00:00"}
